Long acting atrial natriuretic peptide therapeutic (Eli Lilly and Company)

N/A

Report date: 2024/03/18 16:42:41

Base Information

Drug NameLong acting atrial natriuretic peptide therapeutic (Eli Lilly and Company)
Drug Alias NameLong-Acting Atrial Natriuretic Peptide (Eli Lilly and Company)LA-ANP (Eli Lilly and Company)
ClassificationBiologics
Mechanisms of ActionAtrial natriuretic peptide receptor modulators
TargetsAtrial natriuretic peptide receptor
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A